Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

5.76
Delayed Data
As of Nov 15
 -0.09 / -1.54%
Today’s Change
3.42
Today|||52-Week Range
6.31
+37.14%
Year-to-Date
No recent news for Progenics Pharmaceuticals Inc.

Today’s Trading

Previous close5.85
Today’s open5.90
Day’s range5.72 - 5.90
Volume310,226
Average volume (3 months)1,122,096
Market cap$497.8M
Data as of 3:59pm ET, 11/15/2019

Growth & Valuation

Earnings growth (last year)-18.99%
Earnings growth (this year)-7.76%
Earnings growth (next 5 years)+2.00%
Revenue growth (last year)+33.54%
P/E ratioNM
Price/Sales20.94
Price/Book4.82

Competitors

 Today’s
change
Today’s
% change
ITCIIntra-Cellular Thera...+0.18+2.04%
STMLStemline Therapeutic...+0.43+4.54%
CYTKCytokinetics Inc+0.06+0.80%
CCXIChemoCentryx Inc+0.09+1.03%
Data as of 4:00pm ET, 11/15/2019

Financials

Next reporting dateMarch 5, 2020
EPS forecast (this quarter)-$0.22
Annual revenue (last year)$15.6M
Annual profit (last year)-$67.7M
Net profit margin-433.09%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
New York, New York

Forecasts